SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® ...
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
A new study presented at IDWeek 2024 reveals that race and socioeconomic vulnerabilities significantly impact vaccine uptake ...
Medpage Today on MSN12h
RSV Vaccine Tied to Fewer Hospitalizations, ED Visits in Older, High-Risk AdultsThe respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...
Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening ...
New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...
ATI-1701 provides full protection against lethal tularemia in animal models after one yearCompany to provide update on tularemia vaccine ...
Medpage Today on MSN1d
Novel Monoclonal Antibody Protects Infants Against RSVClesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback